Elevation Oncology, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (May 17, 2024).
In: Clinical Oncology Week, 2024-06-04, S. 2314-2314
serialPeriodical
Zugriff:
Elevation Oncology, Inc. has filed a Form 4 with the U.S. Securities and Exchange Commission (SEC) on May 17, 2024. The company's SIC code is 2836, which corresponds to Biological Products. The SEC filing is a statement of changes in beneficial ownership of securities. The filing contains information about the reporting person's relationship to the company and any purchases or sales of equity securities. For more information, the SEC filing can be found at the provided link. [Extracted from the article]
Copyright of Clinical Oncology Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Elevation Oncology, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (May 17, 2024).
|
---|---|
Zeitschrift: | Clinical Oncology Week, 2024-06-04, S. 2314-2314 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1543-6799 (print) |
Schlagwort: |
|
Sonstiges: |
|